Who owns Edwards Lifesciences Corporation?
Institutional ownership of EW from SEC Form 13F filings across 736 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
736
13F holders
$38.44B
value, 2026 filers
75.8%
of shares outstanding (436.7M sh)
86
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of EW's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 58.8M | $5.32B | 0.1% | 10.2% | +11.8% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 37.6M | $3.40B | 0.1% | 6.5% | -0.3% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 26.4M | $2.39B | 0.1% | 4.6% | 0.0% |
| 4 | JPMORGAN CHASE & CO | 22.8M | $2.08B | 0.1% | 4% | +4.8% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 16.8M | $1.52B | 0.3% | 2.9% | -23.5% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 15.4M | $1.39B | 0.1% | 2.7% | +17.5% |
| 7 | Bank of New York Mellon Corp | 14.1M | $1.27B | 0.2% | 2.4% | -15.9% |
| 8 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13.0M | $1.18B | 0.9% | 2.3% | +1.5% |
| 9 | Aristotle Capital Management, LLCNEW | 8.7M | $783.9M | 1.6% | 1.5% | new |
| 10 | ALLIANCEBERNSTEIN L.P. | 8.7M | $693.5M | 0.2% | 1.5% | +149.8% |
| 11 | FMR LLC | 8.4M | $763.1M | 0.0% | 1.5% | -41.8% |
| 12 | NORGES BANKNEW | 8.4M | $757.5M | 0.1% | 1.5% | new |
| 13 | BROWN ADVISORY INC | 7.4M | $666.3M | 1.0% | 1.3% | +4.8% |
| 14 | BANK OF AMERICA CORP /DE/ | 6.7M | $605.4M | 0.0% | 1.2% | +72.3% |
| 15 | Artisan Partners Limited Partnership | 6.6M | $599.4M | 1.0% | 1.2% | +27.4% |
| 16 | MORGAN STANLEY | 6.3M | $573.5M | 0.0% | 1.1% | -10.2% |
| 17 | DEUTSCHE BANK AG\ | 5.7M | $516.6M | 0.1% | 1% | -5.7% |
| 18 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 5.7M | $513.6M | 0.2% | 1% | +200.3% |
| 19 | NORTHERN TRUST CORP | 5.7M | $513.0M | 0.1% | 1% | -2.6% |
| 20 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.5M | $496.5M | 0.1% | 1% | +0.6% |
| 21 | GOLDMAN SACHS GROUP INC | 4.5M | $411.5M | 0.0% | 0.8% | -10.5% |
| 22 | Legal & General Group Plc | 4.3M | $389.1M | 0.1% | 0.7% | -3.3% |
| 23 | CITADEL ADVISORS LLC | 4.0M | $361.7M | 0.0% | 0.7% | +670.3% |
| 24 | Invesco Ltd. | 4.0M | $359.8M | 0.0% | 0.7% | -17.4% |
| 25 | Sixth Street Partners Management Company, L.P.NEW | 3.7M | $334.1M | 57.7% | 0.6% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.